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Abstract  31	  
Brain injury following stroke affects neurogenesis in the adult mammalian brain. However, a 32	  
complete understanding of the origin and fate of the endogenous neural stem cells (eNSCs) in 33	  
vivo is missing. Tools and technology that allow non-invasive imaging and tracking of eNSCs in 34	  
living animals will help to overcome this hurdle. In this study, we aimed to monitor eNSCs in a 35	  
photothrombotic (PT) stroke model using in vivo bioluminescence imaging (BLI). In a first 36	  
strategy, inducible transgenic mice expressing firefly luciferase (Fluc) in the eNSCs were 37	  
generated. In animals that received stroke, an increased BLI signal originating from the infarct 38	  
region was observed. However, due to histological limitations, the identity and exact origin of 39	  
cells contributing to the increased BLI signal could not be revealed. To overcome this limitation, 40	  
we developed an alternative strategy employing stereotactic injection of conditional lentiviral 41	  
vectors (Cre-Flex LVs) encoding Fluc and eGFP in the subventricular zone (SVZ) of Nestin-Cre 42	  
transgenic mice, thereby specifically labeling the eNSCs. Upon induction of stroke, increased 43	  
eNSC proliferation resulted in a significant increase in BLI signal between 2 days and 2 weeks 44	  
after stroke, decreasing after 3 months. Additionally, the BLI signal relocalized from the SVZ 45	  
towards the infarct region during the 2 weeks following stroke. Histological analysis at 90 days 46	  
post stroke showed that in the peri-infarct area, 36% of labeled eNSC progeny differentiated into 47	  
astrocytes, while 21% differentiated into mature neurons. In conclusion, we developed and 48	  
validated a novel imaging technique that unequivocally demonstrates that nestin+ eNSCs 49	  
originating from the SVZ respond to stroke injury by increased proliferation, migration towards 50	  
the infarct region and differentiation into both astrocytes and neurons. In addition, this new 51	  
approach allows non-invasive and specific monitoring of eNSCs over time, opening perspectives 52	  
for preclinical evaluation of candidate stroke therapeutics. 53	  
54	  
	  3	  
	  
Introduction 55	  
The presence of endogenous neural stem cells (eNSCs) in the adult mammalian brain, including 56	  
human brain, is now widely accepted (Altman, 1962, 1963; Curtis et al., 2005; Eriksson et al., 57	  
1998). Two brain regions, i.e. the SVZ of the lateral ventricles and the subgranular zone (SGZ) 58	  
of the hippocampal dentate gyrus, are recognized as primary regions of adult neurogenesis (Ming 59	  
and Song, 2005). Under physiological conditions, eNSCs in the SVZ divide and their progeny 60	  
migrates tangentially via the rostral migratory stream (RMS) to the olfactory bulb (OB). Upon 61	  
arrival in the OB, neuroblasts differentiate into local interneurons and integrate into the 62	  
glomerular and granular layers (Alvarez-Buylla and Garcia-Verdugo, 2002). Pathological 63	  
conditions, including brain injury and stroke, affect adult neurogenesis (Curtis et al., 2005; Gray 64	  
and Sundstrom, 1998; Liu et al., 1998). Stroke, a common cause of morbidity and mortality 65	  
worldwide, deprives the brain of oxygen and glucose (Flynn et al., 2008). Following stroke, 66	  
neurogenesis augments the number of immature neurons in the SVZ (Jin et al., 2001; 67	  
Zhang et al., 2008). Neuroblasts (positive for the marker doublecortin, DCX) migrate towards 68	  
sites of ischemic damage and upon arrival, phenotypic markers of mature neurons can be 69	  
detected (Arvidsson et al., 2002; Parent et al., 2002). On the other hand, retroviral labeling of the 70	  
SVZ showed that cells migrated to the lesion and differentiated into glia (Goings et al., 2004), 71	  
demonstrating that following injury, the SVZ can generate both neural cell types. Some studies 72	  
showed that SVZ-derived progenitors can differentiate into medium spiny neurons in the 73	  
striatum after stroke (Collin et al., 2005; Parent et al., 2002), whereas others claimed that the 74	  
newborn cells are fate restricted to interneurons or glia (Deierborg et al., 2009; Liu et al., 2009). 75	  
Whether SVZ neural progenitors can alter their fate, integrate in the injured circuits and survive 76	  
for long time periods is still a matter of debate (Kernie and Parent, 2010). Up till now, specific 77	  
labeling of eNSCs in the SVZ and the follow-up of the migration of their progeny to the 78	  
ischemic area over time has not yet been shown.  79	  
 80	  
Apart from the primary neurogenic niches, other brain regions, e.g. the cortex, contain cells that 81	  
become multipotent and self-renew after injury (Komitova et al., 2006). Although mature 82	  
astrocytes do not divide in healthy conditions, they can dedifferentiate and proliferate after stab 83	  
wound injury and stroke (Buffo et al., 2008; Sirko et al., 2013). While these proliferating 84	  
astrocytes remained within their lineage in vivo, they formed multipotent neurospheres in vitro 85	  
(Buffo et al., 2008; Shimada et al., 2010). Therefore, these reactive astrocytes may represent 86	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an alternative source of multipotent cells that may be beneficial in stroke.  87	  
 88	  
A major hurdle when studying endogenous neurogenesis is the lack of methods to monitor these 89	  
processes in vivo, in individual animals over time. We and others attempted to label eNSCs by 90	  
injection of iron oxide-based particles in the lateral ventricle or SVZ (Nieman et al., 2010; 91	  
Shapiro et al., 2006; Sumner et al., 2009; Vreys et al., 2010), or by lentiviral vectors (LVs) 92	  
encoding a reporter gene into the SVZ (Vande Velde et al., 2012) to monitor stem cell migration 93	  
along the RMS with magnetic resonance imaging (MRI). Although MRI provides high 94	  
resolution, it suffers from low in vivo sensitivity and gives no information on cell viability and 95	  
non-specific signal detection cannot be excluded. Rueger et al. described in vivo imaging of 96	  
eNSCs after focal cerebral ischemia via positron emission tomography (PET) imaging (Rueger et 97	  
al., 2010), however, the cells responsible for the PET signal could not be identified. 98	  
Alternatively, transgenic mice expressing Fluc driven by a DCX promoter allowed monitoring of 99	  
adult neurogenesis using in vivo BLI (Couillard-Despres et al., 2008). However, the robust BLI 100	  
signal emitted from the SVZ, leading to scattering and projection of these photons to the OB, 101	  
impedes direct visualization of eNSC migration from the SVZ towards the OB. Moreover, when 102	  
the DCX+ neuroblasts differentiate into mature neurons, they lose the Fluc expression. In a first 103	  
part of the present study, we generated inducible transgenic mice that express Fluc in the nestin+ 104	  
eNSCs, to monitor a stroke-induced eNSC response with BLI. 105	  
 106	  
An alternative strategy to efficiently and stably introduce Fluc in the eNSCs is by stereotactic 107	  
injection of LVs into the SVZ, which allowed us and others to monitor the migration of eNSCs 108	  
and their progeny towards the OB with BLI (Guglielmetti et al., 2013; Reumers et al., 109	  
2008). However, since LVs transduce both dividing and post-mitotic cells, not only eNSCs but 110	  
also neighboring astrocytes and mature neurons are labeled after injection of constitutive LVs in 111	  
the SVZ (Geraerts et al., 2006). As a result, in line with the data described in transgenic mice, a 112	  
high BLI signal emerges from the site of injection that interferes with the measurement of the 113	  
migrating cells (Reumers et al., 2008). To overcome the latter, we developed new conditional 114	  
Cre-Flex LVs in a second part of this study. These Cre-Flex LVs incorporate Cre-lox technology, 115	  
allowing that Fluc and eGFP are restrictively expressed in eNSCs after injection in the SVZ of 116	  
transgenic Nestin-Cre mice. While numerous research groups have previously described 117	  
stroke-induced eNSC behavior (Arvidsson et al., 2002; Parent et al., 2002), we here report for the 118	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first time successful in vivo imaging and characterization of long-term eNSC responses after 119	  
stroke. 120	  
 121	  
Materials & methods 122	  
 123	  
Animals 124	  
 125	  
Animal studies were performed in accordance with the current ethical regulations of the KU 126	  
Leuven. Nestin-CreERT2 mice (a kind gift from Dr. Amelia J. Eisch (University of Texas 127	  
Southwestern Medical Center, Dallas, TX) (Lagace et al., 2007)) and B6.Cg-Tg(Nes-cre)1Kln/J 128	  
(Jax labs stock nr 003771, (Tronche et al., 1999)) were crossbred with C57BL/6-Tyrc-2J/J (Jax 129	  
labs, stock nr 000058), creating white furred albino mice in a C57BL/6 genetic background. 130	  
White furred inducible Nestin-CreERT2 mice were crossbred with ROSA26-LoxPstop- 131	  
LoxP(L-S-L)-luciferase transgenic mice (Safran et al., 2003) (Jax labs, stock nr 005125), 132	  
indicated as Nestin-CreERT2/Fluc mice. To induce Fluc expression, mice received tamoxifen 133	  
intraperitoneally (ip) or orally at 180 mg/kg dissolved in 10% EtOH/90% sunflower oil for 5 134	  
consecutive days. BrdU was administered as previously published (Geraerts et al, 2006). For the 135	  
stroke follow-up, Fluc expression was induced in 11 Nestin-CreERT2/Fluc mice by oral 136	  
tamoxifen treatment. Four days later, the animals were divided into 2 groups: 8 mice received a 137	  
PT stroke and 2 mice received a sham treatment; one mouse died during tamoxifen induction. 138	  
Three Cre-negative littermates that received a stroke were added as controls.  139	  
 140	  
White furred B6.Cg-Tg(Nes-cre)1Kln/J mice, here referred to as Nestin-Cre mice, were 141	  
stereotactically injected with Cre-Flex LV in the SVZ at the age of 8 weeks. One week after 142	  
stereotactic injection, Nestin-Cre mice received a PT stroke (n = 33) or sham treatment 143	  
(n = 10). A Cre-negative littermate that received a stroke was added as control.  144	  
 145	  
Mice were genotyped by PCR using genomic DNA and primers previously described (Lagace et 146	  
al., 2007). 147	  
 148	  
Lentiviral vector construction and production 149	  
 150	  
We designed a new conditional LV system based on the Cre/loxP mechanism, here referred to as 151	  
Cre-Flex (Cre-mediated flip-excision). The Cre-Flex LVs carry a reporter cassette encoding GFP 152	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and Fluc flanked by a pair of mutually exclusive lox sites. The reporter cassette is activated after 153	  
Cre recombination (flip-excision, Fig. 3A). For the construction of the Cre-Flex plasmids,we 154	  
used the pCHMWS-eGFP plasmid as a backbone (Geraerts et al., 2006). As illustrated in Fig. 155	  
3A, pairs of heterotypic loxP_loxm2 recombinase target sites were cloned respectively, upstream 156	  
and downstream of eGFP using synthetic oligonucleotide adaptors. To enable efficient 157	  
recombination, 46-bp spacers were inserted in between both lox sites. In this plasmid, eGFP was 158	  
replaced by the coding sequence for eGFP-T2A-Fluc (Ibrahimi et al., 2009). All cloning steps 159	  
were verified by DNA sequencing. Cre-Flex LVs were generated and produced by the Leuven 160	  
Viral Vector Core essentially as described previously (Geraerts et al., 2005; Ibrahimi et al., 161	  
2009). Before the start of the in vivo experiments, the LV-Cre-Flex was validated in cell 162	  
culture (Supplementary Fig. 1). 163	  
 164	  
Lentiviral vector injections 165	  
 166	  
Mice were anesthetized by ip injection of ketamine (75 mg/kg; Ketalar, Pfizer, Brussels, 167	  
Belgium) and medetomidin (1 mg/kg; Domitor, Pfizer), and positioned in a stereotactic head 168	  
frame (Stoelting, Wood Dale, Illinois, USA). Using a 30-gaugeHamilton syringe (VWR 169	  
International, Haasrode, Belgium), 4 µL of highly concentrated Cre-Flex LV was 170	  
injected in the SVZ at a rate of 0.25 µL/min. After injection of 2 µL, the needle was raised 171	  
slowly over a distance of 1 mm. After injection of the total volume the needle was left in place 172	  
for an additional 5min to allow diffusion before being slowly redrawn from the brain. SVZ 173	  
injections were performed at the following coordinates relative to Bregma: anteroposterior 174	  
0.5 mm, lateral−1.5 mm and dorsoventral−3.0–2.0 mm. After surgery, anesthesia was reversed 175	  
with an ip injection of atipamezol (0.5 mg/kg; Antisedan, Orion Pharma, Newbury, Berkshire, 176	  
UK). 177	  
 178	  
Stroke models 179	  
 180	  
Anesthesia was provided with 2% isoflurane/O2 gas anesthesia (Halocarbon Products 181	  
Corporation, New Jersey, USA) through a facemask. The PT strokes were induced according to 182	  
Vandeputte et al. (2011). Briefly, a vertical incision was made between the right orbit and the 183	  
external auditory canal. Next, the scalp and temporalis muscle were retracted. After intravenous 184	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(iv) injection of the photosensitizer rose Bengal (20 mg/kg; Sigma Aldrich, St Louis, USA) 185	  
through the tail vein, photoillumination was performed for 5 min. Photoillumination 186	  
with green light (wave length, 540 nm; band width, 80 nm) was achieved using a xenon lamp 187	  
(model L-4887; Hamamatsu Photonics, Hamamatsu City, Japan) with heat-absorbing and green 188	  
filters. The irradiation at intensity 0.68 W/cm2 was directed with a 3-mm optic fiber, the head of 189	  
which was placed on the sensory motor cortex. Focal activation of the photosensitive dye 190	  
resulted in local endothelial cell injury leading to microvascular thrombosis and circumscribed 191	  
cortical infarctions (Watson et al., 1985). Sham-operated animals underwent the exact same 192	  
procedure as the animals with a stroke, except for the 5 min photoillumination. 193	  
 194	  
Transient occlusion of the middle cerebral artery (MCA) was done using the intraluminal 195	  
filament technique previously described (Dirnagl and members of the MCAO-SOP group, 2009), 196	  
although in our experiments the MCA was occluded for 20 min. 197	  
 198	  
MR imaging 199	  
 200	  
For MRI data acquisition, mice were anesthetized with isoflurane (Halocarbon) in O2 (2.5% for 201	  
induction, 1.5–2% for maintenance). MR images were acquired using a Bruker Biospec 9.4 Tesla 202	  
small animal MR scanner (Bruker BioSpin, Ettlingen, Germany; horizontal bore, 20 cm) using a 203	  
cross-coil setup consisting of a 7.2 cm linearly polarized resonator for transmission and a mouse 204	  
head surface coil for signal reception as described before (Oosterlinck et al., 2011; Vandeputte et 205	  
al., 2011). In brief, the following protocols were used: (a) T2 maps using a MSME sequence 206	  
(10 echoes with 10 ms spacing, first TE=10 ms, TR=2000 ms, 16 interlaced slices of 0.4 mm, 207	  
100 µm2 in plane resolution); (b) T2-weighted MRI using a RARE sequence (TEeff = 71ms, TR 208	  
= 1300 ms, 100 µm3 isotropic resolution) and (c) high-resolution T2*-weighted 3D FLASH (TR 209	  
= 100 ms, TE = 12 ms, 100 µm3 isotropic resolution). The location of the needle tract after 210	  
stroke was measured with the Bruker Biospin software Paravision 5.x. 211	  
 212	  
In vivo bioluminescence imaging 213	  
 214	  
The mice were imaged in an IVIS 100 system (PerkinElmer, Waltham, MA, USA). Anesthesia 215	  
was induced in an induction chamber with 2% isoflurane in 100% oxygen at a flow rate of 1 216	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L/min and maintained in the IVIS with a 1.5%mixture at 0.5 L/min. Before each imaging 217	  
session, the mice were injected iv with 126 mg/kg D-luciferin (Promega, Leiden, the 218	  
Netherlands) dissolved in PBS (15 mg/mL). Next, they were positioned in the IVIS and 219	  
consecutive 1 or 2min (depending on the experiment) frames were acquired until the maximum 220	  
signal was reached. Data are reported as the total flux (p/s/cm2/sr) from a specific region of 221	  
interest (ROI) of 12.5 mm2. 222	  
 223	  
Ex vivo bioluminescence imaging 224	  
 225	  
Immediately after in vivo BLI imaging, mice were sacrificed by cervical dislocation, decapitated 226	  
and the brain was dissected. The brain was placed in an acrylic brain matrix (Harvard apparatus, 227	  
Holliston, MA, USA) and sliced in 1.0 mm-thick sections. Next, these sections were imaged for 228	  
1 min in the IVIS. 229	  
 230	  
Immunohistochemistry 231	  
 232	  
Animals were sacrificed with an ip overdose (15 µL/g) of pentobarbital (Nembutal, CEVA Santé 233	  
Animale, Libourne, France) and transcardially perfused with 4% paraformaldehyde (PFA) in 234	  
PBS. Brains were removed and postfixed for 24 h with PFA. 50 µm thick coronal sections were 235	  
treated with 3% hydrogen peroxide and incubated overnight with the primary antibody, rabbit 236	  
anti-eGFP (made in-house, 1:10000 (Baekelandt et al., 2003)) or a rabbit anti-Cre recombinase 237	  
(1:3000 (Lemberger et al., 2007)), in 10% normal swine serum and 0.1% Triton X-100. The 238	  
sections were then incubated in biotinylated swine anti-rabbit secondary antibody (diluted 1:300; 239	  
Dako, Glostrup, Denmark), followed by incubation with streptavidin horseradish peroxidase 240	  
complex (Dako). Immune-reactive cells were detected by 3,3′-diaminobenzidine, using H2O2 as 241	  
a substrate. For 5-bromo-2′-deoxyuridine (BrdU) detection, sections were pre-treated for 30 min 242	  
in 2 N HCl at 37 °C, blocked in 0.1 M borate buffer for 20 min, rinsed 3 x 10 min in PBS before 243	  
incubation with rat anti-BrdU (1:400, Accurate chemical, NY, USA) in 10% horse serum, 244	  
followed by incubation with biotinylated donkey anti-rat secondary antibody (Jackson 245	  
ImmunoResearch Laboratories). The number of eGFP+ cells was estimated with an unbiased 246	  
stereological counting method, by employing the optical fractionator principle in a computerized 247	  
system, as described previously (Baekelandt et al., 2002) (StereoInvestigator, MicroBright-Field, 248	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Magdeburg, Germany). 249	  
 250	  
For immunofluorescent stainings, sections were treated with PBS-10% horse serum-0.1% Triton 251	  
X-100 for 1 h. Next, sections were incubated overnight at 4 °C in PBS–0.1% Triton X-100 with 252	  
the following antibodies: chicken anti-eGFP (1:500, Aves labs, Tigard, OR) and rabbit anti-glial 253	  
fibrillary acidic protein (GFAP) for astroglial cells and type B cells (1:500, Dako), goat anti-254	  
doublecortin (DCX) for migrating neuroblasts (1:200, Santa Cruz Biotechnology), or rabbit anti-255	  
neuronal nuclei (NeuN) for mature neurons (1:1000, EnCor Biotechnology Inc., Gainesville, FL, 256	  
USA). The next day, sections were incubated with the appropriate mixture of the following 257	  
fluorescently labeled secondary antibodies at room temperature for 2 h: donkey anti-chicken 258	  
(FITC, 1:200, Jackson Immuno Research Laboratories), donkey anti-goat (Alexa 555, 1:400, 259	  
Molecular Probes) or donkey anti-rabbit (Alexa 647, 1:400, Molecular Probes). Next, the 260	  
sections were washed in PBS- 0.1% Triton X-100 and mounted with Mowiol. Fluorescence was 261	  
detected with a confocal microscope (FV1000, Olympus) with a 488 nm, a 559 nm and a 633 nm 262	  
laser. The signal from each fluorochrome was collected sequentially. For the quantification of 263	  
double and triple positive cells, all GFP+ cells in the right SVZ, corpus callosum and stroke 264	  
region (one section per animal) were analyzed at 40X using z-plane confocal microscopy with 1 265	  
µm steps. All images shown correspond to projections of 18 µm z-stacks, except Fig. 6F which is 266	  
a single focal plane. Brightness, contrast and background were adjusted equally for the entire 267	  
image using ‘brightness and contrast’ controls in Image J. 268	  
 269	  
Statistics 270	  
 271	  
All statistical analyses were performed in Prism 5.0 (GraphPad Software). The statistical tests 272	  
that were used are indicated in the figure legends. Data are represented as mean ± standard error 273	  
of the mean (s.e.m.). p-values are indicated as follows: *p b 0.05, **p b 0.01, and 274	  
***p b 0.001. 275	  
 276	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Results 277	  
Nestin-CreERT2/Fluc mice show an increased BLI signal after stroke 278	  
 279	  
To monitor a stroke-induced eNSC response with BLI we initially used a transgenic strategy, 280	  
where Nestin-CreERT2 mice were crossbred with ROSA26-loxP-stop-loxP(L-S-L)-luciferase 281	  
transgenic mice. In the resulting Nestin-CreERT2/Fluc mice, Fluc expression is induced 282	  
specifically in the nestin+ eNSCs following administration of tamoxifen (Lagace et al., 2007). 283	  
First, we monitored the migration of eNSC progeny from the SVZ to the OB with BLI in healthy 284	  
adult Nestin-CreERT2/Fluc mice. BLI was performed 1 week before and 1, 4, 8, 15 and 20 285	  
weeks after tamoxifen administration in healthy Nestin-CreERT2/Fluc mice (n = 5) or Cre-286	  
negative littermates (n= 4). At all time points investigated, no distinct in vivo BLI signals could 287	  
be detected in the neurogenic regions of Nestin-CreERT2/Fluc mice and in Cre-negative 288	  
littermates (Figs. 1A–C). Furthermore, there was no significant increase in BLI signal originating 289	  
from the OB over time in Nestin-CreERT2/Fluc mice (Figs. 1 B,C). Although no differences in 290	  
in vivo BLI signal could be detected, ex vivo BLI analysis showed a 2 to 3 fold higher BLI signal 291	  
in the OB and SVZ of Nestin-CreERT2/Fluc mice compared to Cre-negative littermates (Figs. 292	  
1D,E). This indicates that Fluc is indeed expressed in eNSCs of the SVZ and in the progeny 293	  
arriving in the OB, as is evidenced by ex vivo BLI, but the number of labeled cells is too low for 294	  
in vivo detection. The latter might be explained by a low neurogenic potential in the Nestin-295	  
CreERT2/Fluc mice, since differences in neurogenic potential between mouse strains have been 296	  
described (Kempermann et al., 1997). Therefore, we evaluated the neurogenic potential in 297	  
Nestin-CreERT2/Fluc mice and in age matched C57BL/6 mice using BrdU (Supplementary Fig. 298	  
2) and showed that proliferation in the SVZ and number of newborn neurons arriving in the OB 299	  
was not different. In conclusion, neurogenesis in SVZ and migration to the OB could not be 300	  
monitored with in vivo BLI in healthy adult Nestin-CreERT2/Fluc mice. 301	  
 302	  
Next, we investigated whether stroke-induced neurogenesis could be monitored in Nestin 303	  
CreERT2/Fluc mice. Nine days after tamoxifen administration, mice either received a PT stroke 304	  
in the right sensorimotor cortex (n=8) or a sham treatment (n=2) (Fig. 2A). Cre-negative 305	  
littermates with stroke were included as controls (n = 3). BLI was performed one day prior to and  306	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 307	  
Fig. 1. Long-term follow-up of Nestin-CreERT2/Fluc mice with BLI. (A,B) A long-term follow-308	  
up of the BLI signal originating from the neurogenic brain regions was performed in Nestin- 309	  
CreERT2/Fluc mice (n = 5) and Cre-negative littermates (n = 4). BLI was performed 1 week 310	  
before and 1, 4, 8, 15 and 20 weeks after ip administration of tamoxifen. The BLI signal 311	  
originating from the SVZ (A) and OB (B) was not significantly different from the background 312	  
signal in Cre-negative littermates. Furthermore, no increase in BLI signal originating from 313	  
the OB was detected over time (B). (C) BLI images of a representative Nestin-CreERT2/Fluc 314	  
mouse 1 week before and 4, 8 and 15 weeks after tamoxifen administration. (D) Ex vivo BLI 315	  
20 weeks after induction shows a higher signal in the neurogenic regions in Nestin-316	  
CreERT2/Fluc mice compared to Cre-negative littermates. (E) Quantification of ex vivo BLI 317	  
signals at 20 weeks shows a 2 to 3 fold higher signal emitted from the SVZ and the OB in the 318	  
Nestin-CreERT2/Fluc mice compared to Cre-negative littermates. 319	  
 320	  
 321	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7, 15, 22 and 33 days after surgery. In Nestin-CreERT2/Fluc mice receiving sham treatment and 322	  
in Cre negative littermates receiving stroke, no in vivo BLI signal could be detected (Figs. 323	  
2B,C). However, in 6 out of 8 Nestin-CreERT2/Fluc mice that received a stroke, a distinct BLI 324	  
signal emerging from the stroke area was detected starting at day 7 (Figs. 2B,C), compared to the 325	  
baseline scan before surgery, being 3.2 ± 0.4 fold higher at 7 days (p b 0.001), 4.2 ± 0.5 fold 326	  
higher at 15 days (p b 0.001), 2.1 ± 0.4 fold higher at 22 days (p b 0.05) and 1.9 ± 0.3 fold higher 327	  
at 33 days (not significant) after surgery (Fig. 2B). Ex vivo analysis was performed after 33 days 328	  
and demonstrated in 3 out of 6 animals a BLI signal emerging from the stroke region, 329	  
corroborating the in vivo measurements and excluding that the signal originated from the skin 330	  
(Fig. 2D). Although the BLI signal emerging from the stroke area could result from 331	  
accumulation of migrating SVZ progeny, alternatively, mature astrocytes in the infarction zone 332	  
might have dedifferentiated upon injury, resulting in nestin and subsequent Fluc activity (Buffo 333	  
et al., 2008). Thus, although a stroke-induced neurogenic response can be detected with in vivo 334	  
BLI in Nestin-CreERT2/Fluc mice, the exact origin of the BLI signal could 335	  
not be identified.  336	  
 337	  
Development and validation of conditional Cre-Flex LVs for specific eNSC labeling 338	  
 339	  
To overcome this limitation, we engineered a viral vector-based system, containing a Cre-Flex 340	  
cassette. The LV encodes a reporter cassette, here encoding eGFP and Fluc linked by a peptide 341	  
2A sequence, in reverse orientation relative to the promoter, that is only activated in cells 342	  
expressing Cre recombinase (LV-Cre-Flex Nb eGFP-T2A-Fluc; Fig. 3A). We injected LV-Cre-343	  
Flex Nb eGFP-T2A-Fluc into Nestin-Cre transgenic mice, which express Cre recombinase under 344	  
the control of the rat nestin promoter and enhancer, limiting Cre expression to eNSCs. As a 345	  
result, eGFP and Fluc expression is specifically activated in eNSCs and their progeny. The use of 346	  
2A-like peptides results in equimolar expression of Fluc and eGFP reporter genes (Ibrahimi et 347	  
al., 2009), enabling BLI and immunohistochemistry for eGFP to identify transduced 348	  
cells in the same animal. 349	  
 350	  
 351	  
 352	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 353	  
Fig. 2. Stroke induces an increase in BLI signal in Nestin-CreERT2/Fluc mice localized to the 354	  
peri-infarct area. (A) Experimental time line for BLI measurements of Nestin-CreERT2/Fluc 355	  
mice after a PT stroke. 9 days after the start of tamoxifen induction, mice received PT stroke 356	  
(n=8) or sham (n= 2) surgery. Cre-negative littermates with stroke were included as controls (n 357	  
=3). (B) Compared to the baseline scan performed before surgery, the in vivo BLI signal 358	  
originating from the stroke region was 3.2±0.4 fold higher at 7 days (repeated measures one way 359	  
ANOVA p b 0.001, followed by Dunnett's post test p b 0.001), 4.2 ± 0.5 fold higher at 15 days 360	  
(Dunnett's post test p b 0.001), 2.1 ± 0.4 fold higher at 22 days (Dunnett's post test p b 0.05) and 361	  
1.9±0.3 fold higher at 33 days (not significant) in stroke animals. (C) Representative in vivo BLI 362	  
signals 33 days after stroke. In 6 out of 8 Nestin-CreERT2/Fluc mice receiving stroke, a 363	  
distinctive in vivo BLI signal originating from the stroke region could be detected, which could 364	  
not be detected in sham or in Cre-negative animals. (D) Representative ex vivo BLI signals 33 365	  
days after stroke. In 3 of the 6 animals with an increased in vivo stroke BLI signal, an ex vivo 366	  
BLI spot in the stroke region could be detected. 367	  
 368	  
 369	  
The LVs were injected in the SVZ of healthy adult Nestin-Cre mice (n = 9) to label the eNSCs 370	  
and the migration of the progeny to the OB was monitored by BLI at 1, 8, 15, 20 and 27 weeks 371	  
after injection (Figs. 3B,C). In line with earlier data (Reumers et al., 2008), a distinct BLI signal 372	  
emerged from the OB at 8 weeks, which gradually increased over time being 3.2 ± 0.3 fold 373	  
higher at 8 weeks (not significant), 4.3 ± 0.8 fold higher at 15 weeks (p b 0.01), 5.1 ± 1.1 fold 374	  
higher at 20 weeks (p b 0.001) and 5.5±1.4 fold higher at 27 weeks (p b 0.001) compared 375	  
to 1 week after injection (Figs. 3B,C). No BLI signal from the OB could be identified in WT 376	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mice 1 or 15 weeks after injection of the Cre-Flex LV (n = 4) (Figs. 3B, C). 377	  
Immunohistochemical detection of Cre+ and eGFP+ cells showed specific labeling of cells lining 378	  
the ventricle wall and labeled eNSC progeny in the OB (Figs. 3D–E–F, respectively). In 379	  
conclusion, the conditional LV-based labeling system combines specific and efficient labeling of 380	  
the eNSC population of the SVZ with the possibility for immunohistochemical analysis of the 381	  
transduced eNSCs and their progeny. Additionally, migration of the eNSC progeny to the OB 382	  
could be monitored in vivo with BLI, which was not feasible in the Nestin- 383	  
CreERT2/Fluc mice. 384	  
 385	  
Stroke-induced neurogenic response in the SVZ is detected by BLI and histology 386	  
 387	  
Cre-Flex LVswere applied to monitor the eNSC response after stroke (Fig. 4A). Adult Nestin-388	  
Cre mice were stereotactically injected with LVCre-Flex Nb eGFP-T2A-Fluc into the right side 389	  
of the SVZ. Seven days post injection, the animals received either a PT stroke in the right 390	  
sensorimotor cortex (n = 21) or sham surgery (n = 9). Stroke lesions were monitored with MRI 2, 391	  
7 and 14 days after surgery (Fig. 4C). BLI measurements were performed 1 day before (baseline) 392	  
and 2, 7, 14, 30 and 90 days after surgery (Figs. 4A,B,D). As a control, a Cre negative mouse 393	  
was injected with the LV-Cre-Flex vector and received a PT stroke. It was monitored until 3 394	  
months after stroke, but no BLI signal could be detected (data not shown). At all time points 395	  
investigated, the sham animals showed no difference in BLI signal compared to the baseline scan 396	  
(Fig. 4D). However, mice with a PT stroke showed a 4.3 ± 0.8 fold increase in BLI signal at 2 397	  
days (p b 0.001), a 6.2 ± 1.6 fold increase at 7 days (p b 0.01), a 7.5 ± 3.3 fold increase at 14 398	  
days (p b 0.05) and a 6.4 ± 3.5 fold increase at 30 days (not significant) (Fig. 4D). At later time 399	  
points, the stroke BLI signal decreased until 90 days after stroke. 400	  
 401	  
The stroke-induced increase in BLI signal was corroborated by stereological quantification of the 402	  
number of eGFP+ cells in the SVZ, striatum, corpus callosum (CC) and peri-infarct area (Figs. 403	  
5A,B).Most eGFP+ cells were detected in the CC, reaching to the stroke area. In sham animals, 404	  
2116 ± 209 eGFP+ cells (n = 7) were counted and this number did not change over time. In 405	  
animals receiving stroke surgery, the number of eGFP+ cells was significantly higher at 2 days 406	  
(4123 ± 674, p b 0.05, n = 7), 7 days (5407 ± 290, p b 0.05, n = 2) and 14 days (4610 ± 222, p b 407	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0.05, n = 4) after stroke, compared to sham animals (Fig. 5B). 90 days after stroke, the number of 408	  
eGFP+ cells decreased and was significantly lower (2382 ± 375, p b 0.05, n = 7) compared to 7 409	  
and 14 days after stroke, corroborating the results obtained by BLI. 410	  
 411	  
 412	  
Fig. 3. Validation of conditional LV-Cre-Flex for specific eNSC labeling. (A) Schematic 413	  
representation of the conditional Cre-Flex LV. The cDNA cassette is flanked by one pair of loxP 414	  
sites (closed arrowheads) and one pair of loxm2 sites (open arrowheads). In the presence of Cre 415	  
recombinase, the DNA sequence between opposing sites is inversed (Flip), resulting in the 416	  
positioning of two homotypic sites in the same orientation. The DNA sequence that is flanked by 417	  
similarly oriented sites is excised (Excision). Cre-mediated inversion can start at the 418	  
loxP or the loxm2 sites, but will always result in the same final product after Cre-mediated 419	  
excision. The end product is an inverted DNA sequence, flanked by two heterotypic sites 420	  
that cannot recombine with one another thereby preventing further inversions. (B) Cre-Flex Nb 421	  
eGFP-T2A-Fluc LV were injected in the SVZ of black furred Nestin-Cre mice (n= 9) or 422	  
Cre-negative littermates (n= 4). The mice were scanned at 1, 8, 15, 20 and 27 weeks post 423	  
injection. A significant increase in BLI signal originating from the OB was detected over time 424	  
in the Nestin-Cre mice (repeated measures one-way ANOVA p = 0.001, followed by Dunnett's 425	  
post test). (C) Representative BLI images of Nestin-Cre and WT littermates at indicated 426	  
time points. Detection of Cre+ (D) and eGFP+ (E,F) cells in the SVZ and OB 4 weeks after 427	  
injection of Cre-Flex_Fluc Nb eGFP LV in the SVZ of Nestin-Cre mice (D–F) Scale bar= 250 428	  
µm. 429	  
 430	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To ensure that the eGFP+ cells originate from labeled eNSCs and not from reactive astrocytes 431	  
that upregulate their nestin promoter and thus Cre upon injury, Cre expression was analyzed 2 432	  
days after stroke (Supplementary Figs. 3A,B). There was no Cre upregulation in the ipsilateral 433	  
SVZ and CC compared to the contralateral hemisphere (Supplementary Fig. 3A), whereas Cre-434	  
positive cells with astrocyte-like morphology were detected in close proximity of the stroke 435	  
lesion (Supplementary Fig. 3B). These cells were mainly present in the cortex on the dorsal 436	  
side of the lesion and to a lesser extent on the lateral side of the lesion. Since the Cre-Flex LVs 437	  
were injected in the SVZ, which is physically distant from the stroke region, and since the Cre-438	  
Flex LVs specifically label cells in the SVZ (Fig. 3E), it is unlikely that these distant reactive 439	  
astrocytes were labeled directly via viral vector injection. Taken together the Cre-Flex LV 440	  
allowed non-invasive monitoring of a stroke-induced transient increase in the number of eGFP+ 441	  
cells, which originated from labeled eNSCs in the SVZ. 442	  
 443	  
In vivo BLI reveals eNSCmigration to the area of infarction and OB following PT stroke 444	  
 445	  
Long-term BLI follow-up of stroke animals not only revealed a transient increase in BLI signal, 446	  
but also a clear shift of the BLI signal towards the stroke lesion was apparent (Fig. 4B). To 447	  
estimate the migration of the BLI signal after stroke, the distance between the BLI hot spot and 448	  
the midline was determined (Fig. 4E). Before stroke surgery, a unifocal signal originating from 449	  
the site of injection was detected, which corresponds to labeled cells in the SVZ (average 450	  
distance of 2.56 ± 0.22 mm from midline). Two days after stroke, a small shift of the BLI 451	  
signal towards the contralateral hemisphere was evident (Fig. 4B), probably due to the induction 452	  
of edema as was detected by MRI (Supplementary Fig. 4A). At 1 and 2 weeks after stroke, a 453	  
significant shift of the BLI spot towards the stroke region was observed in 9 out of 10 animals 454	  
(average distance of 4.62 ± 0.25 mm from midline, p b 0.001 compared to baseline) (Figs. 4B,E), 455	  
suggesting migration of the eNSC progeny towards the stroke area. In the sham-operated animals 456	  
no shift was detected at any of the time points (data not shown). Since dynamic changes of 457	  
edema or changes in ventricle size due to loss of viable brain tissue might affect the location of 458	  
the BLI signal, the animals were also imaged with MRI on the same day of the BLI (Fig. 4A). 459	  
The needle tract was used as a reference and its shift due to edema formation or changes in 460	  
ventricle size was monitored (Supplementary Figs. 4A,B). The needle tract shift 14 days after 461	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stroke compared to the time of injection was 0.39±0.04mm(n=9),which was considerably smaller 462	  
than the shift of the BLI signal (2.06 mm). Although a small enlargement of the ventricles was 463	  
detected in the animals with a PT stroke, its effect on the migration of BLI signal was limited. 464	  
 465	  
 466	  
Fig. 4. BLI detects the increase and migration of eNSC progeny after PT stroke in Nestin-Cre 467	  
mice injected with the LV-Cre-Flex. (A) Experimental time line for imaging of the eNSC 468	  
response in a PT stroke model in mice. Seven days after stereotactic injection of LV-Cre-Flex in 469	  
the SVZ of Nestin-Cre mice, the animals received a PT stroke in the right sensorimotor cortex 470	  
(n=21) or sham surgery (n=9). The animals were imaged with BLI and MRI, for additional 471	  
anatomical information, at indicated time points. (B) Consecutive BLI images of a Nestin-Cre 472	  
mouse before and after stroke injury reveal a time-dependent increase of BLI signal and a shift of 473	  
the BLI signal towards the stroke lesion. Three months after stroke, a second BLI signal can be 474	  
discriminated between the eyes, representing migration of labeled eNSC progeny to the OB. This 475	  
signal could not be distinguished before and 2, 7, 14 days after stroke. (C) Representative T2-476	  
weighted MR image 7 days after stroke surgery of a Nestin-Cre mouse. The stroke region in the 477	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right sensory motor cortex is depicted with a red dotted line. (D) Quantification of relative BLI 478	  
signal. 2 days after stroke surgery, a 4.3 ± 0.8 fold increase in BLI signal emanating from the 479	  
SVZ was detected (n = 22) in comparison to the sham animals (n = 9) (Mann–Whitney test p b 480	  
0.001). A more pronounced increase (6.2 ± 1.6 fold) was detected at 7 days (n = 14 versus n = 9) 481	  
(p b 0.01), 14 days (7.5 ± 3.3 fold increase in stroke (n =8) versus sham (n=4) animals (p b 0.05)) 482	  
and at 30days (6.4±3.5 fold increase in stroke (n=6) versus sham(n=2) animals) after surgery. 90 483	  
days after stroke surgery, a relative photon flux of 2.01 ±1.1 difference was detected in stroke 484	  
animals (n=7) compared to 1.1± 1.0 in sham animals (n=2). (E) Migration of the BLI hot spot 485	  
towards the stroke region. Before stroke surgery, the average distance of the BLI spot is 2.56 ± 486	  
0.22 mm from the midline (n = 9). 7–14 days after stroke surgery, the average distance of the 487	  
BLI spot is 4.62 ± 0.25 mm from the midline (n= 9, t-test p b 0.001). 488	  
 489	  
Since most studies have investigated stroke-induced neurogenesis in models of middle cerebral 490	  
artery occlusion (MCAO) (Parent et al., 2002; Thored et al., 2007), a small experiment where 491	  
animals received either MCAO (n=4) or sham surgery (n=3) was performed (Supplementary 492	  
Fig. 5). The MCAO model provides MCA territory infarctions, involving the striatum and the 493	  
frontoparietal cortex, after the insertion of a monofilament that blocks the origin of MCA, 494	  
whereas the PT stroke model involves the intravenous administration of a photosensitive dye 495	  
followed by laser irradiation of any exposed region of the skull. 496	  
 497	  
Although a 5 fold increase in BLI signal was detected over time in the animal with the largest 498	  
MCAO stroke lesion, there was no re-location of the BLI signal, most likely due to the large 499	  
stroke size and its location, which restrains the migration and localization of the labeled cells 500	  
within a region of the ischemic striatum (Ohab and Carmichael, 2008).  501	  
 502	  
In the group receiving PT stroke, long-term BLI follow-up revealed a clear BLI signal between 503	  
the eyes in 5 out of 8 animals at 3 months after stroke, in line with migration of eNSC progeny to 504	  
the OB (Fig. 4B). The origin of BLI signal emerging from the OB was corroborated 505	  
histologically by a gradual increase in the number of eGFP+ cells in the OB over time, being 2.7 506	  
± 0.6 fold higher at 14 days (not significant) and 12.8 ± 2.0 fold higher (p b 0.05) at 90 days 507	  
compared to 7 days after stroke surgery (Figs. 5C,D). These results provide additional evidence 508	  
that the LV-Cre-Flex specifically labeled the eNSCs in the SVZ.  509	  
 510	  
In conclusion, injection of LV-Cre-Flex in the SVZ of Nestin-Cre mice allowed monitoring both 511	  
the migration of eNSC progeny from the SVZ 512	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to the stroke region and to the OB with BLI. 513	  
 514	  
Fig. 5. Histological characterization of long-term stroke-induced eNSC response. (A)  515	  
Representative immunohistochemistry for eGFP of the SVZ, CC and stroke area at baseline and 516	  
2, 7, 14 days and 3 months after stroke surgery. Most eGFP+ cells were detected in the CC, with 517	  
some cells reaching the stroke area. The presence of eGFP+ cells surrounding the stroke area is 518	  
most pronounced at 14 days and 3 months after surgery. Magnifications of specific details are 519	  
integrated in the figure. (B) Stereological quantification of the total number of eGFP+ cells in the 520	  
SVZ, CC, striatum and stroke area after PT stroke. In sham animals, the number of eGFP+ cells 521	  
was constant over time and on average 2116 ± 210 eGFP+ cells were detected (n = 7). In stroke 522	  
animals, the number of eGFP+ cells was significantly higher at 2 days (4123 ± 674, n = 7), 7 523	  
days (5407 ± 290, n = 2) and 14 days (4610 ± 222, n = 4) after stroke, compared to sham animals 524	  
(One-way ANOVA p b 0.001, followed by Bonferroni post test p b 0.05, indicated by $). 90 days 525	  
after stroke, the number of eGFP+ cells was significantly lower (2382±375, n=7, Bonferroni post 526	  
test p b 0.05, indicated by #) compared to 7 and 14 days after stroke. (C) Representative 527	  
immunohistochemical images of eGFP+ cells in the OB of mice with PT stroke at 7, 14 and 90 528	  
days after surgery. (D) Stereological quantification of the number of eGFP+ cells in the OB at 7 529	  
days (84±24, n=2), 14 days (225±48, n =4) and 90 days (825±167, n=7) after stroke. 3 months 530	  
after stroke, the number of eGFP+cells was significantly higher compared to 7 days after stroke 531	  
(Kruskal-Wallis test p b 0.05, followed by Dunn's post test p b 0.05). The time-dependent 532	  
increase corresponds to the migration of eGFP+ eNSC progeny from the SVZ to the OB. 533	  
 534	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 535	  
Fig. 6. Labeled eNSCs differentiate into astrocytes and neurons in the stroke region. (A,B) 536	  
Double immunofluorescence staining for eGFP (green) and GFAP (red) of the CC (A) and stroke 537	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region (B) of the ipsilateral hemisphere 90 days after stroke. Filled white arrowheads indicate 538	  
eGFP+ eNSCs and astrocytes. (C,D) Triple immunofluorescence staining for eGFP (green), 539	  
DCX (red) and NeuN (blue) of the CC (C) and stroke region (D). (C) Filled white arrowheads 540	  
indicate eGFP+ migrating neuroblasts. (D) Filled white arrowheads and arrow indicate eGFP+ 541	  
mature neurons. (E) Quantification of double and triple labeled cells. (F) Magnification of 542	  
eGFP+ neuron indicated with arrow in (D). Scale bar: (A–D)= 100 µm; (F) = 25 µm. 543	  
 544	  
eNSC progeny differentiates into astrocytes and neurons in the peri-infarct region 545	  
 546	  
Since injection of LV-Cre-Flex in Nestin-Cre mice results in the expression of Fluc and eGFP in 547	  
the eNSCs and their progeny, a detailed histological analysis of the transduced cell population 548	  
and its progeny can be performed. In animals killed 90 days after PT stroke, light producing 549	  
cells (152 ± 30 eGFP+ cells counted per animal, n = 3) were identified by double and triple 550	  
immunofluorescence stainings (eGFP in combination with GFAP or DCX and NeuN (Fig. 6)). In 551	  
the SVZ and the CC, 77 ± 7% of eGFP+ cells were GFAP+ eNSCs and astrocytes, 8 ± 2% 552	  
were DCX+ migrating neuroblasts and b1% were NeuN+ mature neurons (Figs. 6A,C,E). A 553	  
different pattern of cellular phenotypes was detected in the peri-infarct region: 36 ± 5% of 554	  
eGFP+ cells were GFAP+ astrocytes, 13 ± 11% were DCX+ migrating neuroblasts, 5 ± 3% were 555	  
DCX+NeuN+ immature neurons and 21 ± 16% were NeuN+ mature neurons (Figs. 6B,D,E). 556	  
Evaluation of differentiation into mature neurons, displayed a high inter-animal variability, with 557	  
one animal showing 50% of eGFP+ cells co-expressing NeuN in the peri-infarct region, while 558	  
the other two animals showed less than 10% coexpression. In the first animal, some eGFP+ 559	  
neurons showed long dendrites covered with many spines (Fig. 6F). These data indicate that the 560	  
labeled eNSCs in the SVZ gave rise to progeny that migrated towards the stroke region where 561	  
they eventually differentiated into both astrocytes and mature neurons.562	  
	  22	  
	  
Discussion 563	  
Detailed knowledge of the biological role and potential of eNSCs is of great importance for the 564	  
success of neuro-regenerative therapies in different neurological disorders, including stroke. 565	  
Therefore, development of non-invasive methods to monitor and study proliferation, migration 566	  
and survival of eNSCs and their progeny in the same animal over time is crucial. The main  567	  
dvantage of cell tracking via BLI is the high sensitivity, especially when cells are located in 568	  
superficial tissues (Massoud and Gambhir, 2003). The present study demonstrates non-invasive 569	  
imaging of the eNSC response after PT stroke in a mouse model using BLI. First, we generated 570	  
double transgenic Nestin-CreERT2/Fluc mice, in which Fluc expression is induced in the eNSCs 571	  
after tamoxifen administration. After stroke, these mice showed an increase in BLI signal in vivo 572	  
(n = 6/8) and ex vivo (n = 3/8) originating from the stroke lesion (Figs. 2B, C). The discrepancy 573	  
in efficiency between the in vivo and ex vivo results can be explained by technical issues, such 574	  
as the time required to dissect the brain tissue immediately after sacrifice, which causes 575	  
differences in oxygenation status of the tissue and enzymatic activity (Deroose et al., 2006). In 576	  
the latter model it was impossible to define the origin of the cells giving rise to the BLI signal 577	  
emerging from the stroke area, which might either originate from accumulation of migrating 578	  
SVZ progeny or from dedifferentiation of local mature astrocytes upon injury, resulting 579	  
in nestin and subsequently, Fluc expression (Buffo et al., 2008). Moreover, although Fluc is 580	  
expressed in eNSCs of the SVZ and eventually in the progeny arriving in the OB, as was 581	  
evidenced by ex vivo BLI (Figs. 1D, E), the number of labeled cells or the expression level of 582	  
Fluc per cell was too low for in vivo detection (Figs. 1A–C). In this way, the effect of stroke on 583	  
the neurogenic process towards the OB could also not be monitored. 584	  
 585	  
In a second approach, we circumvented these drawbacks by devising conditional Cre-Flex LVs 586	  
to inject in the SVZ of Nestin-Cre mice. Specific induction of Fluc and eGFP in the eNSCs and 587	  
their progeny allows both BLI and immunohistochemical characterization of the neurogenic 588	  
process. In contrast to the first approach using double transgenic mice, in vivo BLI signals from 589	  
the SVZ and eventually from the OB could be detected (Fig. 3C),most probably due to the higher 590	  
Fluc expression levels. Induction of a PT stroke resulted in a significant gradual increase in BLI 591	  
signal between 2 days and 2 weeks after surgery (Figs. 4B,D). The latter was underscored by an 592	  
increase in eGFP+ cells in the SVZ, striatum, CC and stroke region (Fig. 5B). Subsequently, the 593	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BLI signal and the number of eGFP+ cells decreased to background levels at 3 months after 594	  
stroke. This transient increase in eNSC progeny is in accordance with two studies describing a 595	  
transient increase in the proliferation and migration of eNSCs following stroke or brain trauma, 596	  
detected by histology using cell type-specific markers (Parent et al., 2002) or by retroviral 597	  
labeling of SVZ cells (Goings et al., 2004). Parent et al. showed that the number of BrdU-labeled 598	  
cells was lower 5 weeks after stroke compared to previous time points, suggesting that many of 599	  
the newly generated cells died (Parent et al., 2002). 600	  
 601	  
In Nestin-Cre mice injected with the Cre-Flex LV, a clear relocalization of the BLI signal 602	  
towards the stroke area was detected between 1 and 2 weeks after stroke surgery. This was 603	  
confirmed histologically by eGFP+ cells moving closer towards the ischemic lesion over 604	  
time (Figs. 4B and 5A). The 1–2 weeks time frame of this migration is in agreement with the 605	  
work of Ohab et al. who detected GFP+ cells, originating from the SVZ, in the peri-infarct cortex 606	  
7 and 14 days after stroke (Ohab et al., 2006). When monitoring eNSC migration after stroke 607	  
with BLI, we encountered some technical hurdles. First, edema formation causes a shift of the 608	  
midline, resulting in a slight apparent re-location of the BLI spot towards the contralateral 609	  
hemisphere, complicating detection of eNSC migration towards the lesion at early time points. 610	  
Second, changes in ventricle size, due to tissue degeneration after stroke may confound the 611	  
imaging results (Karki et al., 2010). Therefore, we combined BLI with MRI, which has a high 612	  
spatial resolution and gives better insight in alterations of the anatomical structure of the brain. 613	  
 614	  
Since labeled cells express a fluorescent reporter (eGFP) in addition to the bioluminescent Fluc 615	  
reporter, the origin and identity of light emitting cells could be determined by 616	  
immunohistochemical stainings. Ninety days after stroke, labeled eNSC progeny differentiated 617	  
into both astrocytes and mature neurons, demonstrating the multipotency of eNSCs upon stroke 618	  
injury (Arvidsson et al., 2002; Goings et al., 2004; Parent et al., 2002). The majority of eGFP+ 619	  
labeled cells in the SVZ, CC and the stroke region expressed GFAP, corroborating astrocytic 620	  
differentiation of eNSC progeny after cortical injury (Goings et al., 2004; Holmin et al., 1997). 621	  
In addition, using tamoxifen-inducible Nestin-CreERT2:R26R-YFP reporter mice, Li et al. 622	  
demonstrated that 45% of eNSC progeny co-expressed GFAP 6 weeks after MCAO, indicating a 623	  
significant gliogenic component (Li et al., 2010).  624	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 625	  
Since stroke injury might induce nestin expression in reactive astrocytes (Buffo et al., 2008; 626	  
Shimada et al., 2010; Sirko et al., 2013) or in vasculature-associated cells in the ischemic core 627	  
(Shin et al., 2013), one could question the source of the eGFP+ cells located around the 628	  
ischemic lesion. However, it has been well described that reactive astrocytes are mainly present 629	  
in the close vicinity of the stroke region. Unbiased stereological quantifications of astrocyte 630	  
proliferation, a hallmark of reactive gliosis, showed that astrocytes respond to stroke injury 631	  
in a spatially graded way (Barreto et al., 2011). The authors showed that most astrocyte 632	  
proliferation occurs within 200 µm of the edge of the infarct. In addition, nestin upregulation of 633	  
reactive astrocytes has been shown to be confined to the peri-infarct region, or to clearly 634	  
demarcate the lesion boundary (Li and Chopp, 1999; Shimada et al., 2010). Since we injected the 635	  
Cre-Flex LV in the SVZ, which is physically distant from the stroke region, and since we did not 636	  
detect any changes in Cre expression in the SVZ or CC, we consider it unlikely to label local 637	  
reactive astrocytes around the stroke region. Another indication that argues against local reactive 638	  
astrocytes as the main origin of labeled cells concerns the localization of the BLI signal: if the 639	  
4.3 fold increase in BLI signal two days after stroke would be caused by labeling of reactive 640	  
astrocytes, one would expect appearance of a new BLI spot emerging from the stroke region, or a 641	  
shift of the existing SVZ BLI spot towards the stroke region. However, we show that this is not 642	  
the case and that there is even a small shift of the original SVZ BLI spot towards the 643	  
contralateral side (Fig. 4B). A clear migration of the BLI spot towards the stroke region was only 644	  
apparent after 7–14 days after stroke. Our data strongly suggest migration of the progeny of 645	  
transduced eNSCs via the CC to the stroke lesion. The increase in BLI signal between the eyes 646	  
and the corresponding increase in the number of eGFP+ cells in the OB over time, points to the 647	  
migration of labeled eNSC progeny from the SVZ to the OB, proving that the eNSCs in the SVZ 648	  
were labeled by the Cre-Flex LV. Several research groups have shown a reduction or diversion 649	  
of normal neuroblast migration from the SVZ to the OB at early time points after cortical lesion 650	  
or stroke (Goings et al., 2004; Ohab et al., 2006). The Cre-Flex LV technology will allow 651	  
longitudinal non-invasive imaging of the effects of brain lesions on rostral migration. 652	  
 653	  
The present study focuses on the response of SVZ-derived Nestin+ eNSCs on stroke injury. 654	  
However, none of the eNSC markers currently available exclusively labels eNSCs and evidence 655	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emerges suggesting eNSC heterogeneity both in the SVZ (Giachino et al., 2013) and the 656	  
SGZ (Bonaguidi et al., 2012; DeCarolis et al., 2013). It would therefore be interesting to apply 657	  
the Cre-Flex LVs in different transgenic mice to compare the contribution of different progenitor 658	  
populations to the stroke-induced neurogenic response (Dhaliwal and Lagace, 2011). In addition, 659	  
the Cre-Flex LVs might also be used to study eNSC response in other disease models 660	  
(Guglielmetti et al., 2013). 661	  
 662	  
In conclusion, we developed a novel technique based on conditional Cre-Flex LVs that allows 663	  
non-invasive imaging of the stroke-induced eNSC response in living mice with BLI. In addition, 664	  
this new technique enables fate mapping of the eNSC progeny after stroke by 665	  
immunohistochemistry. Our BLI and histological data are consistent with the prevailing 666	  
hypothesis that stroke induces a transient increase in proliferation in the SVZ, a targeted 667	  
migration of eNSC progeny towards the stroke region and differentiation in both astrocytes and 668	  
neurons. For this reason, we believe that this technology may facilitate preclinical validation of 669	  
neuro-regenerative strategies in rodent stroke models. 670	  
 671	  
Supplementary data to this article can be found online at 672	  
http://dx.doi.org/10.1016/j.nbd.2014.05.014. 673	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Supplementary Figures 950	  
 951	  
S Fig1. Validation of Cre-Flex LV in cell culture. (A) Western blot shows no detectable 952	  
expression of eGFP or Fluc in 293T cells after transduction with Cre-Flex >< eGFP-T2A-Fluc 953	  
LV; expression is induced when the cells are co-transduced with a LV encoding for Cre. (B) 954	  
Luciferase activity and eGFP fluorescence confirm that transgene expression following 955	  
transduction of 293T cells is conditional on Cre activity. 956	  
 957	  
 958	  
S Fig2. Neurogenic potential in Nestin-CreERT2/Fluc mice. BrdU staining of brain sections of 959	  
the SVZ and OB of a Nestin-CreERT2/Fluc mouse (upper panel) compared to an age-matched 960	  
C57BL/6 mouse (lower panel). BrdU was administered as previously published (Geraerts et al, 961	  
2006). There was no significant difference in the number of BrdU+ cells in both the SVZ (left) 962	  
and OB (right) of Nestin-CreERT2/Fluc mice compared to C57BL/6 mice. 963	  
 964	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 965	  
S Fig3. Upregulation of Cre expression near the stroke region. Cre staining of the SVZ, CC and 966	  
stroke region at 2 days after stroke. (A) There were no major changes in Cre expression in the 967	  
ipsilateral SVZ and CC in comparison to the contralateral hemisphere. (B) Cre expression in the 968	  
ipsilateral SVZ (left panel), the cortex on the dorsal side of the stroke region (middle panel), the 969	  
striatum on the lateral side of the stroke region (right panel). Cre expressing cells with astrocytic 970	  
morphology were mainly detected in the cortex (middle panel). Scale bar (A) = 250 µm; 971	  
(B) = 25 µm. 972	  
 973	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 974	  
S Fig4. Anatomical changes in the brain of mice with PT stroke. (A) Representative T2-weighted 975	  
MRI of edema formation 2 days after stroke, at times resulting in a shift of the BLI signal 976	  
towards the midline. (B) T2-weighted MRI of an animal 14 days after stroke surgery with an 977	  
enlarged ventricle in the ipsilateral hemisphere. The stroke regions in the right hemisphere are 978	  
marked with a red dotted line. 979	  
 980	  
S Fig 5. Increased BLI signal in a Nestin-CreERT2 mouse after MCAO. (A) Nestin-CreERT2 981	  
mice were injected in the SVZ with the Cre-Flex LV. One week later, expression was induced by 982	  
5 days of tamoxifen treatment via oral gavage. 2 weeks after tamoxifen treatment, mice received 983	  
MCAO or sham surgery. The mice were scanned prior to and 7, 14 and 21 days after stroke/sham 984	  
surgery. This image represents the follow-up of a single mouse, showing a 5 fold increase in BLI 985	  
signal after MCAO compared to baseline. This increase was detected in 1 out of 4 MCAO 986	  
animals and was not observed in the sham-operated animals (n = 3). (B) This panel represents 987	  
the corresponding T2-weighted MR image of the animal depicted in (A) at 20 days after surgery. 988	  
The stroke area in the right sensory motor cortex is marked with a red dotted line. (C) eGFP+ 989	  
cells in the CC of the same animal 22 days after stroke. 990	  
